Xoma | XOMA - Lucro Operacional





Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Ardelyx USD 5.1M 431K 2025-12
aTyr Pharma USD 24.47M 51.21M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Curis USD -12.51M 40K 2024-06
Eli Lilly USD 8.99B 599.9M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Incyte USD 383.88M 47.43M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Novartis USD 4.06B 437M 2025-12
Novartis USD 4.06B 521M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Xoma USD -15.64M 5.56M 2024-09